Social Media Community Guidelines
Allena Pharmaceuticals Social Media Community Guidelines
Our social media profiles provide exciting opportunities to connect and interact with individuals and organizations interested in our company. We intend to use these platforms to share company news and announcements, provide corporate information and live updates from medical conferences, and participate in important community outreach and advocacy efforts.
It is our goal to interact with as many social media users as possible when appropriate, but please note we may not be able to reply individually to all messages received on these platforms. We reserve the right to block or mute users posting inappropriate or offensive material at our sole discretion, with or without notice.
As a global biopharmaceutical company, we work in a highly-regulated healthcare industry and may often be unable to engage in some discussions about products and will not offer medical advice using social media. Please note social media posts by independent users do not necessarily reflect the views of Allena Pharmaceuticals and might contain information on products which may or may not be available in any particular country, and if available, have received approval or market clearance by a governmental regulatory body for different indications and restrictions in different countries. Allena Pharmaceuticals does not control or endorse this third-party content and makes no representations regarding its accuracy. Visithttps://www.allenapharma.com/ or contact Allena Pharmaceuticals via email at email@example.com or by phone at 617-467-4577 to obtain the appropriate product information for your country of residence.
If you believe you have experienced an adverse event or side effect related to an Allena Pharmaceuticals product, please contact your healthcare provider immediately. You can also visit the FDA safety information and adverse reporting program online. If you post information on social media about an adverse event or side effect, please note we may be required to contact you for additional information to comply with regulatory guidelines.